Hims & Hers Health, INC Form 4 insider transactions

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on March 26, 2025, according to a Form 4 filing with the SEC.

Oluyemi Okupe, CFO of Hims & Hers Health, Inc., sold 23,118 shares of Class A Common Stock at an average price of $32.4066 on March 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director and Chief Medical Officer Patrick Harrison Carroll reports acquisition and disposal of Hims & Hers Health, Inc. Class A Common Stock and Restricted Stock Units.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on March 14 and March 17-18, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. reports the vesting and disposal of restricted stock units to cover tax obligations.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

Director Christiane Pendarvis reports acquisition of Hims & Hers Health Class A Common Stock through vesting of Restricted Stock Units.

Irene Becklund, PAO of Hims & Hers Health, reports the vesting and sale of Class A Common Stock and Restricted Stock Units.

Chief Commercial Officer Michael Chi reports the vesting and settlement of Restricted Stock Units (RSUs) and associated tax withholding, resulting in changes to his beneficial ownership of Hims & Hers Health, Inc. stock.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units on March 14, 2025.

CEO Andrew Dudum reports the acquisition of 306,406 Restricted Stock Units (RSUs) in Hims & Hers Health, Inc. on March 11, 2025, according to a Form 4 filing.

Irene Becklund, PAO of Hims & Hers Health, reports the sale of 2,203 shares of Class A Common Stock and the acquisition of 22,284 Restricted Stock Units.

Director Christiane Pendarvis sold 12,500 shares of Hims & Hers Health, Inc. Class A Common Stock at $40 per share on March 5, 2025.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. exercised stock options to acquire 2,530 shares of Class A Common Stock at $5.01 per share on March 5, 2025.

Irene Becklund, PAO of Hims & Hers Health, sold 2,913 shares of Class A Common Stock at $45.14 per share on March 3, 2025, under a pre-arranged 10b5-1 trading plan.

Patrick Harrison Carroll, Chief Medical Officer and Director at Hims & Hers Health, Inc., acquired 56,529 Restricted Stock Units (RSUs) on March 3, 2025, which will vest over a four-year period.

Chief Financial Officer of Hims & Hers Health, Oluyemi Okupe, reports the acquisition of 183,719 Restricted Stock Units (RSUs) tied to Class A Common Stock, vesting quarterly over four years.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., acquired 197,851 restricted stock units (RSUs) on March 3, 2025, which will vest over a four-year period.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., acquired 169,587 Restricted Stock Units (RSUs) on March 3, 2025, which will vest over a four-year period.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., was granted 98,925 Restricted Stock Units (RSUs) on March 3, 2025, according to a Form 4 filing with the SEC.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum reports multiple transactions involving Class A Common Stock, including option exercises and sales, executed under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 4,152 shares of Class A Common Stock at a price of $60.69 on February 18, 2025.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares of Class A Common Stock according to a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on February 12, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares of Class A Common Stock on February 10, 2025, according to a Form 4 filing with the SEC.

Hims & Hers Health CFO Oluyemi Okupe executed stock option exercises and sales of Class A Common Stock on February 10, 2025, according to a Form 4 filing.

Oluyemi Okupe, CFO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on February 4, 2025, under a pre-arranged Rule 10b5-1 trading plan.

CEO Andrew Dudum reports the vesting and disposal of Restricted Stock Units (RSUs) and the acquisition of Class A Common Stock due to the achievement of a performance threshold.

Andrew Dudum, CEO of Hims & Hers Health, exercised stock options and sold 100,000 shares of Class A Common Stock on January 31, 2025, according to a Form 4 filing with the SEC.